Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.
Cheung
N K
NK
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Burch
L
L
Kushner
B H
BH
Munn
D H
DH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use* / Q000633:toxicity; D001853:Bone Marrow / Q000473:pathology; D002648:Child; D004341:Drug Evaluation; D006801:Humans; D009000:Monocytes / Q000473:pathology; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000473:pathology / Q000628:therapy*
D000911:Antibodies, Monoclonal